TPST
TPST
NASDAQ · Biotechnology

Tempest Therapeutics Inc

$0.83
+0.00 (+0.31%)
As of Sep 28, 10:41 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +5,157.3% upside
Low Target $35.70
Average Target $43.72
High Target $58.20
Current Price $0.83
Current
$0.83
Target
$43.72
$35.70 $43.72 avg $58.20
Scenario Analysis
Bear Case
$35.70
4,192.9%
Low target
Base Case
$43.72
+5,157.3%
Avg target
Bull Case
$58.20
+6,898.6%
High target
Risk/Reward
1.6x
Balanced
Price in Context
52-Week High
$12.23
-93.2% from high
52-Week Low
$0.74
+11.9% from low
Target vs 52W High
$43.72
+257.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -3.3%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.4%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +138.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -24.2%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.4%